Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- PMDA to Enhance Cooperation with Authorities in Other East Asian Countries: Mr Mori
April 7, 2008
- SELF-MEDICATION NEWS IN BRIEF
April 7, 2008
- Notices Received for 35 Collaborative Multinational Trials: Mr Mori
April 7, 2008
- Serious Effort Needed to Bring about Improvements : FJPWA President Matsutani
April 7, 2008
- Takeda Discontinues Development of TAK-475
April 7, 2008
- BUSINESS NEWS IN BRIEF
April 7, 2008
- R&D NEWS IN BRIEF
April 7, 2008
- Acquisition of Teikoku Medix to Help Nichi-iko Strengthen Ties with Wholesalers
April 7, 2008
- Advanced Healthcare Service Assessment Program Started
April 7, 2008
- Consumption of Generics Will Gradually Increase: Mr Sawai
April 7, 2008
- Ideal Anticoagulants Inhibit Pathological Thrombosis without Causing Hemorrhage: PSJ Symposium
April 7, 2008
- Generics with Added Value Presented at PSJ Symposium
April 7, 2008
- Mevalotin Useful Against CAD in Elderly Women
April 7, 2008
- Surveys Show Increasing Interest in Generics
April 7, 2008
- Self-Injection at Home a Boon to Patients with Migraines
April 7, 2008
- Aiming at Eliminating "Drug Lag": New PMDA Chief Executive
April 7, 2008
- Long QT Risk Can Be Assessed Using Proarrhythmia Model
April 7, 2008
- Chuikyo Approves NHI Prices for 21 Products (14 APIs)
April 7, 2008
- Toyama Chemical to Review Licensing Policy
April 7, 2008
- TOPICS／Pfizer Starts Publicity Campaign on Growth Disorders in Girls
April 7, 2008
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…